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Urinary IgG excretion as a prognostic factor 
in idiopathic membranous nephropathy
L. J. M. R e ic h e r t , R . A. R K o e n e  and J. F. M. W e t z e l s
Abstract. In membranous nephropathy it would be of great value to be able to identify in an early 
phase patients at highest risk for disease progression, since potentially toxic treatment could then be 
restricted to these patients only. We measured renal hemodynamics, serum proteins and urinary pro­
tein excretion in 22 patients with membranous nephropathy, nephrotic syndrome and normal renal 
function (endogenous creatinine clearance >85 ml/min). These patients were followed for a mean o f  
56 months. Renal function deteriorated in nine patients. When using univariate analysis, deteriora­
tion of renal function appeared to be associated with a low serum albumin and transferrin, high uri­
nary transferrin, (3-microglobulin, and IgG excretion, but not with renal hemodynamics. A step-up 
procedure, used for selecting variables associated with survival, showed that IgG excretion was in­
dependently associated with renal function deterioration. In patients with membranous nephropathy 
and normal renal function, the urinary excretion rate of IgG predicts future renal function outcome.
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Introduction
While membranous nephropathy is the most com­
mon cause of nephrotic syndrome in adults, its treatment study we analyzed the res
that the urinary (32-microglobulin excretion can reason 
ably well predict renal outcome in patients with
[Reichert et al. 1995 j. In the
'itb
is still a matter of debate [Lewis 1 anous renal hemodynamics and urinary excretion
nephropathy may be secondary to an underlying disease proteins to determine if s our
i* »
such as hepatitis B, systemic lupus erythematosus, malig- ability to identify patients at highest risk for subsequent 
nancy, or occur as a side effect of drug treatment. In most renal function deterioration. Our data suggest that the uri 
cases, however, no underlying cause can be found. About nary excretion of IgG may be a valuable parameter in this 
a quarter of the patients with so-called idiopathic mem­
branous nephropathy experience a spontaneous remission 
of proteinuria, which is a predictor for a favourable renal
outcome et al. 1 « *; remaining Subjects and methods
quarters of the patients continue to have proteinuria, and 
half of these patients will progress to renal insufficiency, >nrr
i f et al. 1988J. Treating all 
patients with methylprednisolone and cyclophosphamide 
or chlorambucil would unjustifiably expose up to 50% of nous nephropathy, a 
the patients to these potentially toxic drugs. Identifying
Twenty-two patients with a biopsy proven membra ©Q
V n  tv*
(i. e. urinary 
I 3.5 g per day and/or a serum
patients at the highest risk for disease progression would albumin i  25 g/1) and normal renal function (endogenous 
provide an opportunity to better direct immunosuppres- creatinine clearance >85 ml/min) were included in the
sive treatment. In a previous study we have demonstrated Patients secondary o f mous
n ephropathy (malignancy,
*  «
\sts ann­ oi* 2 use of
could induce membranous nephropathy) were excluded.
During the study the patients were not treated with eylo i*a
Received October 3 1, 19%; in revised form March 7, 1997 toxic drugs. Until
Correspondence to Dr. J. F, M. Wetzels, Division of Nephrology, nate day steroids. 
University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, for treatment with
patients were treated with
 ^I 1 i* s were rt
The Netherlands.
on alternate days or only 
supportive treatment. No difference was noted in renal
cHO Reichert, Koene and Wetzels
outcome with respect to prednisone treatment, which is were made with the non-parametric two-sample rank sum 
in agreement with more recent studies [Cattran et al. test. Correlations were calculated using Spearman’s rank
1989], Diuretics and antihypertensive treatment were correlation test. Possible factors associated with renal
given if required. The study protocol was approved by outcome were selected by univariate analysis. Subse- 
the Hospital Ethics Committee. All patients gave quently, a step-up procedure was used for selecting van- 
informed consent. ables independently associated with survivial [Krall et al.
1975]. A p value less than 0.05 was considered signifi­
cant.
During the baseline study were Results
We have studied 19 male and 3 female patients.
except when voiding. During voiding they were in an 
upright or sitting position, to ensure complete emptying 
of the bladder. Glomerular filtration rate was measured Mean age of the patients was 46 years (median 48.5 
using a continuous infusion technique. Blood and urine years, range 24-60 years), serum creatinine 95 |xmot/l 
samples were taken at regular intervals. The renal clear- (median 90 jxmol/l, range 70-145 fxmol/1), and creatinine
ances of Inutest (polyfructosan, Laevosan-Gesellschaft, clearance 123 ml/min (median 117 ml/min, range 87 to
Linz, Austria) and PAH (Para-aminohippurate) were used 210 ml/min). Total proteinuria averaged 8.0 g per day
as markers for glomerular filtration rate and effective (median 6.45 g per day, range 2.8-20.3 g per day) and
renal plasma flow respectively. Since (32-microglobulin serum albumin was 21 g/1 (median 18, range 7-32 g/1).
is unstable in acidic urine (pH <6.0) all patients received Patients were studied 3 months (median 2, range 0 to
four grams of sodium bicarbonate the evening before the 11 months) after renal biopsy. Patients were followed for at
measurements. Urine samples collected at short intervals least 12 months after measurement o f renal hemodynam-
during the renal hemodynamic measurements were used ics and protein excretion. Deterioration of renal function
for the analysis of urinary proteins. The freshly voided was defined as a doubling of serum creatinine at any time
urine samples were centrifuged and stored for at most interval in all but one patient. In this patient immunosup-
one week at 4° C, or otherwise kept at -70° C. In blood pressive therapy was started already when
and urine samples the concentrations of albumin, IgG creatinine had increased by 25% within 3 months. Exclu-
and transferrin were measured by immunonephelometry sion of this patient did not influence the statistical results,
using antibodies whose specificity was checked by Ouch- Dehydration and renal vein thrombosis as a cause of 
terlony double immunodiffusion and immunoelectrophor- 
esis. Details of the nephelometric procedure
serum
the
wererenal
The clinical characteristics and
on
measurement of albumin have been described [Elving et parameters of the patients divided according to final renal 
al. 1989J. For the measurements o f transferrin we have outcome are shown in Tables 1 and 2. No significant dif­
used a rabbit anti-human transferrin antibody (DAKO ferences were noted between the groups with respect to 
A 120, Dakopatts, Glostrup, Denmark) which was diluted age, time of diagnosis to start of the study, presence of 
300-fold in a diluent of phosphate-buffered isotonic saline hypertension or length of follow-up. We also did not find
(phosphate 5 mM, pH 7.4) containing 20 g/1 of polycthy- a m GFR or I).
lene glycol 4000 and 20 g/1 polyethylene glycol 2000. Although filtration fraction was numerically lower in the
s with future deterioration of renal func-For the measurements of IgG we have used a rabbit anti- group of 
human IgG (DAKO A090 or Q331), which was diluted 
200-fold in a diluent containing 100 mM phosphate, 10 
of BSA and polyethylene glycol as described above. We 
have used a standard serum which was calibrated against From the data 
the WHO 067-86 standard (for IgG) and against commer­
cially available standards for albumin and transferrin
. Serum and urinary p2-microgiobulin
was not significant (p = 0.09). A 
scatter plot of the individual data confirms that there is a
groups (Figure 1).ap
I it is
creatinineaneously
overestimates real GFR in this group of 
mean
were measured by RIA (Pharmacia, Uppsala, Sweden), clearance and inulin clearance was 38 ml/min (95% con-
Inulin, PAH, and creatinine were measured using stan- fidence interval 24-52 ml/min; p <0. ).
dard colorimetric methods. of GFR by using creatinine clearance was especially evi­
dent when GFR was reduced.
In blood and urine samples collected during the
amics we measured the' a,1'
Values are given as means (SD) or medians (range)
. Statistical
levels of different proteins. At the time of biopsy there
snce in proteinuria between the 
groups. At the time of the renal function study there also
as no s
U rin a r y  Ig G  e x c re tio n  f o r  ID M  p r o g n o s is  81
/ Characteristics of the study patients at the start of the study 200
Group 1 
Stable renal
Group 2
Deteriorating renal
function (n = 13) function (n = 9)
Sex (male/female) 10/3 9/0
Age at biopsy (range) 48 (36-57) 43 (24-60)
Serum creatinine (p,mol/l) 89 ± 12 102 ± 2 4
Endogenous creatinine 117 ± 2 4 132 ± 38
clearance (ml/min)
Inulin clearance (ml/min) 87 ± 2 8 82 ± 36
Effective renal plasma flo1* 551 ±179 607 ± 185
(ml/min)
Filtration fraction 16 ± 1.8 13.6 ± 4.4
Proteinuria at biopsy 6.2 (3.2-20.3) 9.2(2.8-15.0)
(g/day)
Hypertension 4 3
Follow-up (months) 57(12-132) 48 (12-108)
Values are given as absolute number of patients, median (range), or
means ±  SD. There are no significant differences
Table 2 Baseline values of serum and urinary proteins in patients with­
out and with deteriorating renal function during follow-up
Group 1 Group 2
Stable renal Deteriorating renal
function (n = 13) function (n = 9)
Serum albumin (g/1) 22.9 ± 5.0 17.2 ±6 .9“
Urinary albumin excretion 4,634(1,180-10,283) 9,410 (2,248-13,848)
(mg/day)
Serum transferrin (g/1) 2.30 ± 0.56 1.60 ± 0.36b
Urinary transferrin 411 (104-916) 1,080(127-1,182)“
excretion (mg/day)
Serum IgG (g/1) 5.3 ± 2.6 4.2 ±2.1
Urinary IgG excretion 98 (52-528) 387 (73-785)“
(mg/day)
Serum (ir-microglobulin 2.30 ± 0.69 2.75 ±1.13
(mg/I)
Urinary p^-microglobulin 174 (61-24,988) 1,020 (129-13,519)"
excretion (ng/min)
Selectivity index 0.16 (0.07-0.36) 0.23 (0.11 -0.31)
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Fig. I Scatter plot of values of GFR and ERPF. Group 1 represents 
patients with stable renal function, group 2 with deteriorating renal 
function during follow-up.
renal prognosis (median 1.14 [0.08-2.42] vs 0.18 
[0.06-2.05]; p <0.01).
As could be expected there was a correlation 
between the excretion of different proteins. Spearman’s 
correlation coefficient between urinary IgG and albumin 
excretion was 0.84, between IgG excretion and transfer­
rin excretion 0.83, and between urinary transferrin and 
albumin excretion 0.92 (all p <0.001). Using a step-up 
procedure for selecting variables associated with survival 
[Krall et al. 1975] only IgG excretion was associated 
with renal function deterioration as a significant explana­
tory variable (p <0.01; Figure 2). A threshold of 250 mg/ 
day proved most discriminative. Only two out of 10 
patients with a value above 250 mg/day had stable renal 
function during follow-up. These two patients had a rela­
tively short follow-up of 15 months. Only one patient out 
of 12 with an IgG excretion below 250 mg/day had a 
subsequent renal function deterioration. This patient had 
a very slow rise in serum creatinine during a period of 
4 years of 10 (xmol/l/year. During the following year, his 
serum creatinine quickly doubled, after which he was 
treated with immunosuppressive therapy. Unfortunately, 
we did not repeat the measurements of IgG excretion in 
this patient. With these results a positive predictive value 
was no significant difference in the level of albuminuria. can be calculated of 80%, a negative predictive value of 
However, urinary p2-microglobulin, transferrin, and IgG 92%, a sensitivity of 89% and a specificity of 85%. In 
excretions were significantly elevated in the group of view of our previous results [Reichert et al. 1995], we 
patients who subsequently developed renal insufficiency, have analyzed more closely the relationship between uri-
Values are given as medians (range) or means ± SD 
1 p <0.05 between the two groups 
11 p <0.01 between the two groups
Serum albumin and serum transferrin were significantly 
lower in this group. Although serum IgG was not signifi-
cantly different, the fractional excretion of IgG was sig- patient because of an urinary pH below 6.0. There was a 
nificantly higher in the group of patients with a poor strong correlation between the excretion of IgG and the
82 Reichert, Koene and Wetzels
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[Toth and Takebayashi 1994, Donadio et al. 1988], mas­
sive proteinuria [Honkanen et al. 1994, Cattran et al. 
1992] and tubulointerstitial changes on biopsy [Wehr- 
mann et al. 1989]. However, all these risk factors lack the 
sensitivity and specificity that is needed to reliably guide 
therapy. The present study was undertaken to investigate 
renal hemodynamics and the urinary excretion rates of 
different proteins and their relation with renal outcome in 
patients with membranous nephropathy and normal renal 
function. Only patients with a nephrotic syndrome at the 
time of renal biopsy were studied, because non-nephrotic 
proteinuria in membranous nephropathy usually carries a 
good prognosis [Schieppati et al. 1993]. In patients with 
renal function impairment at the time of diagnosis renal 
function usually continues to deteriorate, if left untreated 
[Davison et al. 1984]. These patients were treated with
immunosuppressi ve els et al.
o
group 1 group 2
et al. 1994] and also not included in this study.
When comparing the two groups of patients divided 
according to renal function outcome we did not observe a
Fig. 2 Scatter plot of values of IgG excretion. Group 1 represents difference in renal hemodynamics (GFR and ERPF).
patients with stable renal function, group 2 with deteriorating renal We observed marked differences in serum and pro
function during follow-up. The threshold value of 250 mg/day is indi- tein levels between patients with and without renal func­
tion deterioration during follow-up. Patients with subse­
quent deterioration of renal function had lower serum 
albumin and transferrin levels, whereas the urinary excre-
cated by the dotted line, p <0.05 between the two groups.
excretion of 32-microglobulin (r = 0.80). When using a tion of transferrin, IgG, and (32-microglobulin was
threshold of 500 ng/min as discriminative value, only increased. Of note, the urinary excretions of total protein
two patients out of nine with a urinary (32-microglobulin or albumin were not significantly different. By multivari-
excretion > 500 ng/min had stable renal function during ate analysis, only IgG excretion was independently asso-
follow-up, whereas renal function deteriorated in only ciated with renal function deterioration. Why is the uri-
two out of with a fo-microglobulin nary excretion of IgG a better predictor of prognosis than
excretion < 500 ng/min. With these results a positive proteinuria, albuminuria or size selectivity? It is tempting
predictive value can be calculated of 78%, a negative to speculate that these differences point to mechanisms
predictive value of 83%, a sensitivity of 78% and a sped- involved in the progression of renal disease in patients
ficity of 83%. The results of urinary pJ2-microglobulin with proteinuria. It has been suggested that the progres-
and IgG excretion concurred in all but one patient. In this sion of renal injury is related to the extent of glomerular
one patient urinary (32-microglobulin excretion was injury and the development o f glomerulosclerosis [Bren-
below the threshold of 500 ng/min, whereas the urinary ner et al. 1982]. In this hypothesis, proteinuria is consid-
excretion of IgG was above the threshold of 250 mg/day. ered to be a mere reflection of glomerular injury. It is
In this patient renal function deteriorated during follow- important to realize that the extent and nature of glomer-
up.
Discussion
ular injury is reflected not only by the level of protein­
uria, but also by the size distribution of urinary proteins. 
Severe glomerular injury results in a loss of size selectiv­
ity of the glomerular basement membrane, with increased 
loss of proteins o f higher molecular weight, such as IgG.
Patients with membranous nephropathy may benefit In clinical practice such a loss of size is
from immunosuppressive therapy [Piccoli et al. 1994, reflected in an increase of the selectivity index (i. e., 
Passerini et al. 1993]. However, in untreated patients clearance o f IgG divided by the clearance of transferrin
membranous nephropathy runs a course in or albumin). Both the level o f proteinuria and the selec-
approximately half of the patients. Therefore, it has been tivity index would be expected to predict renal function 
advocated to limit therapeutic measures to patients with outcome. However, this is found in only a few studies 
an unfavourable prognosis [Glassock 1991]. Risk factors [Collaborative Study of the Adult Idiopathic Nephrotic
for the development of renal failure include male sex Syndrome 1979, Mallick et al. . We suggest that
[Hopper et al. 1981], old age [Cameron 1979, Schieppati s can be explained by the fact that the level of protein-
et al. decreased renal at presentation uria and size selectivity are not necessarily correlated.
Urinary IgG excretion fo r IDM prognosis 83
•*»
fl L’tffcIgG excretion may be a particular good marker of renal phropathy at highest risk for 
injury because it combines information on the level of Measuring urinary IgG excretion may be of help in guid-
oration.
proteinuria and the loss of size selectivity.
Admittedly, the role of glomerular injury in the pro­
gression of renal disease has been questioned. In recent between 
years it has been demonstrated that the rate of deteriora­
tion of renal function is correlated more with tubulointer- 
slitial injury than with glomerular injury [Bohle et al.
19901. Proteinuria may play a central role in the induc­
tion of tubulointerstitial injury [Eddy 1994]. The mecha- Acknowledgments 
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